Physician

David Michael Pilkington, M.D.

According to 2025 Medicare claims, David Pilkington, M.D. (NPI: 1295751931) practices dermatology in the Merced, CA market, with the plurality of this provider's patient population coming from Merced, CA. This provider's primary affiliated billing organization is GOLDEN STATE DERMATOLOGY ASSOCIATES, INC. (NPI: 1700860871; TIN: 68-0299684) and primary practice location at 95340-8219.

Pilkington's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,984 traditional Medicare patients, billed 25,641 HCPCS/CPT codes, and received $778,317 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,533 prescription claims across 547 beneficiaries totaling $514,121 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 135 records totaling $2,036. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $185,223 to $514,121. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$525K$1.1M2015 Medicare payment: $1,013,521 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $942,293 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $934,861 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,050,986 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,033,187 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $679,164 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $795,342 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $847,330 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $796,973 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $778,317 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,76024,264$1,013,521
20162,66123,216$942,293
20172,53923,598$934,861
20182,70528,345$1,050,986
20192,68828,080$1,033,187
20201,67325,196$679,164
20211,88827,056$795,342
20221,84427,288$847,330
20231,83126,811$796,973
20241,98425,641$778,317

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$257K$514K2015 Drug cost: $185,223 (USD; Tot_Drug_Cst)2016 Drug cost: $114,217 (USD; Tot_Drug_Cst)2017 Drug cost: $64,263 (USD; Tot_Drug_Cst)2018 Drug cost: $56,196 (USD; Tot_Drug_Cst)2019 Drug cost: $153,582 (USD; Tot_Drug_Cst)2020 Drug cost: $232,635 (USD; Tot_Drug_Cst)2021 Drug cost: $324,611 (USD; Tot_Drug_Cst)2022 Drug cost: $346,630 (USD; Tot_Drug_Cst)2023 Drug cost: $450,965 (USD; Tot_Drug_Cst)2024 Drug cost: $514,121 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015320780$185,223
2016295694$114,217
2017366861$64,263
2018426972$56,196
20194541,068$153,582
2020374982$232,635
20214181,088$324,611
20223921,123$346,630
20234491,297$450,965
20245471,533$514,121

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths1,0481,483$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,3592,052$66
17000Destruction of precancer skin growth, 1 growth1,4452,379$39
88305Pathology examination of tissue using a microscope, intermediate complexity7581,387$31
17003Destruction of precancer skin growth, 2-14 growths1,24110,987$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab16476$115,289
Enbrel SureclickEtanercept12336$85,999
Dupixent PenDupilumab13364$49,775
Dupixent SyringeDupilumab14392$49,658
Clobetasol PropionateClobetasol Propionate1364,247$5,054

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.135$2,036Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Michael Pilkington, M.D.?

Tedicare shows public-source Medicare data for David Michael Pilkington, M.D. (NPI 1295751931), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Michael Pilkington, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Michael Pilkington, M.D.?

David Michael Pilkington, M.D. is linked to GOLDEN STATE DERMATOLOGY ASSOCIATES, INC. (billing NPI 1700860871) in the available physician profile data.

Does David Michael Pilkington, M.D. have Open Payments data?

David Michael Pilkington, M.D. has 135 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.